Clinical Trials Directory

Trials / Completed

CompletedNCT05289141

Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients

Status
Completed
Phase
Study type
Observational
Enrollment
229 (actual)
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since the beginning of COVID-19 pandemic situation, several modes of ventilation have been tried to correct the hypoxaemia induced by SARS-CoV-2 virus. A few recent studies have concluded that high-flow nasal oxygen therapy (OptiFlow™) is beneficial in COVID-19. All mainly conclude that the use of OptiFlow™ avoid intubations and decrease hospitalization duration in critical care services. At the emergency medical service 83 (SAMU 83), it has been decided to extend this ventilation mode during patient secondary transfers (transfer from an intensive care unit/other hospital unit/emergency department to another hospital's intensive care unit). The emergency medical service 83 has equipped its intensive-care ambulances with OptiFlow™ in order not to interrupt this ventilation mode during transport. The hypothesis is that patients with a severe respiratory form of COVID-19 transported from one health facility to another by the emergency medical service 83 on high-flow nasal oxygen therapy has a reduced risk of intubation compared to the other modes of non-invasive ventilation (NIV) and High Concentration oxygen Masks (HCM).

Detailed description

Retrospective observational study in France including COVID-19 infected patients taken care of by the emergency medical service 83 (SAMU 83) for a secondary transport between1st March 2020 and 31th December 2021.

Conditions

Interventions

TypeNameDescription
DEVICEUse of high flow nasal oxygen therapyUse of high flow nasal oxygen therapy during secondary transport by emergency medical service 83 (SAMU 83).
DEVICEUse of other non-invasive ventilation or high concentration oxygen masksUse of other non-invasive ventilation or high concentration oxygen masks during secondary transport by emergency medical service 83 (SAMU 83).

Timeline

Start date
2022-03-24
Primary completion
2022-04-25
Completion
2022-04-25
First posted
2022-03-21
Last updated
2022-10-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05289141. Inclusion in this directory is not an endorsement.